The rate of positive head-up tilt (HUT), specificity, and same-day rep
roducibility of an HUT at 60 degrees combined with a low-dose isoprote
renol infusion was assessed in the following patients: 120 consecutive
patients with recurrent unexplained syncope, 30 healthy patients in a
control group, and 30 patients with documented syncope not related to
a vasodepressor reaction, HUT was positive in 61% (73 of 120) of pati
ents with unexplained syncope, The false-positive rate in both the con
trol and documented syncope groups was 6.6%. The mean isoproterenol do
se infused was 1.4 +/- 0.5 mu g/min, 1.3 +/- 0.4 mu g/min, and 1.3 +/-
0.5 mu g/min, respectively (p = NS), HUT was positive during the drug
free stage in 30 (25%) of 120 patients, and isoproterenol infusion wa
s necessary in the remaining 43 (36%) patients, Immediate reproducibil
ity was assessed in 75 patients, and HUT response was reproduced in 37
(82%) of 45 patients with a baseline positive HUT and in 28 (93%) of
30 patients with a baseline negative response, Overall, ''sensitivity,
'' specificity, and reproducibility were 61%, 93%, and 86%, respective
ly, Clinical variables that increased the probability of a positive ou
tcome were age less than or equal to 50 years and two or more syncopal
episodes in the preceding 6 months in the absence of structural heart
disease, These data support the use of an HUT protocol with low-dose
isoproterenol infusion for the assessment of patients with recurrent s
yncope.